South-Eastern Asia: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in South-Eastern Asia

The Southeast Asian prophylactic medicaments containing insulin market totaled $X in 2022, stabilizing at the previous year. Over the period under review, consumption, however, recorded a resilient expansion. Over the period under review, the market hit record highs at $X in 2020; however, from 2021 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in South-Eastern Asia

In value terms, prophylactic medicaments containing insulin production reached $X in 2022 estimated in export price. Overall, production, however, showed resilient growth. The most prominent rate of growth was recorded in 2017 when the production volume increased by 65% against the previous year. The level of production peaked at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in South-Eastern Asia

After ten years of growth, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by -12.5% to X tons in 2022. Over the period under review, exports, however, posted a significant increase. The growth pace was the most rapid in 2013 with an increase of 232% against the previous year. Over the period under review, the exports reached the peak figure at X tons in 2021, and then declined in the following year.

In value terms, prophylactic medicaments containing insulin exports plummeted to $X in 2022. Overall, exports, however, recorded significant growth. The growth pace was the most rapid in 2020 with an increase of 267% against the previous year. Over the period under review, the exports reached the peak figure at $X in 2021, and then shrank dramatically in the following year.

Exports by Country

Malaysia represented the major exporting country with an export of around X tons, which amounted to 60% of total exports. It was distantly followed by Singapore (X tons), making up a 39% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by Singapore (with a CAGR of +173.5%).

In value terms, Malaysia ($X) and Singapore ($X) constituted the countries with the highest levels of exports in 2022.

In terms of the main exporting countries, Singapore, with a CAGR of +183.0%, saw the highest rates of growth with regard to the value of exports, over the period under review.

Export Prices by Country

The export price in South-Eastern Asia stood at $X per ton in 2022, dropping by -5.2% against the previous year. In general, the export price, however, recorded a slight increase. The most prominent rate of growth was recorded in 2019 an increase of 73% against the previous year. Over the period under review, the export prices attained the maximum at $X per ton in 2021, and then contracted in the following year.

Average prices varied noticeably amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Malaysia ($X per ton), while Singapore stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Singapore (+3.5%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in South-Eastern Asia

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported in South-Eastern Asia; increasing by 9.8% on the previous year. In general, imports showed a prominent expansion. The growth pace was the most rapid in 2016 with an increase of 37% against the previous year. The volume of import peaked in 2022 and is likely to see gradual growth in years to come.

In value terms, prophylactic medicaments containing insulin imports expanded slightly to $X in 2022. Overall, imports saw a prominent increase. The growth pace was the most rapid in 2014 when imports increased by 29%. Over the period under review, imports hit record highs in 2022 and are likely to see gradual growth in the near future.

Imports by Country

The countries with the highest levels of prophylactic medicaments containing insulin imports in 2022 were Indonesia (X tons), Thailand (X tons), the Philippines (X tons), Vietnam (X tons) and Singapore (X tons), together finishing at 93% of total import. It was distantly followed by Malaysia (X tons), comprising a 6% share of total imports.

From 2012 to 2022, the biggest increases were recorded for Singapore (with a CAGR of +33.9%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Vietnam ($X), Indonesia ($X) and Singapore ($X) constituted the countries with the highest levels of imports in 2022, together comprising 66% of total imports.

Singapore, with a CAGR of +29.9%, saw the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in South-Eastern Asia stood at $X per ton in 2022, declining by -4.5% against the previous year. Over the period under review, the import price saw a mild reduction. The pace of growth was the most pronounced in 2018 an increase of 9.1%. The level of import peaked at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Vietnam ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Vietnam (-0.7%), while the other leaders experienced a decline in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :